Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults.
Sugammadex is a modified gamma-cyclodextrin designed for the selective reversal of neuromuscular blockade induced by rocuronium or vecuronium. Its core process involves encapsulation of the aminosteroid molecule to form a stable complex, rapidly restoring spontaneous ventilation. The chemical formula is C48H72O24 with CAS No. 176025-02-2.
Contraindicated in patients with known hypersensitivity to sugammadex or cyclodextrins. Strictly monitor for anaphylaxis and bradycardia post-administration. Store vials at controlled room temperature (20°C–25°C) away from direct light; do not freeze.